承業醫 (4164)
承業醫 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$506.35M, down 4.1% from a year earlier. EPS over the last four quarters totals NT$1.17.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2012-10-24
- Founded
- 2009-11-27
- Paid-in capital
- NT$1.95B
- Common shares issued
- 195,310,989
- Legal name
- 承業生醫投資控股股份有限公司
- Website
- https://www.chcg.com
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$506.35M | +54.6% | -4.1% |
| 2026-08 | NT$327.60M | +0.3% | +15.4% |
Year to date: +9.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.32 |
| 2026 Q1 | 0.13 |
| 2025 Q4 | 0.36 |
| 2025 Q3 | 0.36 |
| 2025 Q2 | 0.23 |
| 2025 Q1 | 0.05 |
| 2024 Q4 | 0.27 |
| 2024 Q3 | 0.56 |
Last four quarters: NT$1.17
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.10 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 6,259 | 0.7% |
| 1,000–5,000 shares | 9,315 | 9.8% |
| 5,001–10,000 shares | 1,507 | 6.0% |
| 10,001–15,000 shares | 548 | 3.6% |
| 15,001–20,000 shares | 309 | 2.9% |
| 20,001–30,000 shares | 291 | 3.8% |
| 30,001–40,000 shares | 111 | 2.0% |
| 40,001–50,000 shares | 89 | 2.1% |
| 50,001–100,000 shares | 171 | 6.2% |
| 100,001–200,000 shares | 82 | 6.0% |
| 200,001–400,000 shares | 40 | 5.6% |
| 400,001–600,000 shares | 13 | 3.2% |
| 600,001–800,000 shares | 11 | 3.9% |
| 800,001–1,000,000 shares | 7 | 3.3% |
| 1,000,001+ shares | 22 | 40.8% |
TDCC data for 2026-10-16: 22 holders own more than 1,000 lots (40.8% of shares), and 6,259 hold less than one lot (0.7%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -140 | 0 | -13 | -153 |
| 2026-10-16 | -3 | 0 | 0 | -3 |
| 2026-10-15 | 260 | 0 | 0 | 260 |
| 2026-10-14 | 59 | 0 | 0 | 59 |
| 2026-10-13 | -22 | 0 | -3 | -25 |
| 2026-10-12 | 83 | 0 | -8 | 75 |
| 2026-10-08 | -21 | 0 | -15 | -36 |
| 2026-10-07 | -108 | 0 | -7 | -115 |
| 2026-10-06 | 151 | 0 | -36 | 115 |
| 2026-10-05 | -51 | 0 | -10 | -61 |
| 2026-10-02 | -35 | 0 | -30 | -65 |
| 2026-10-01 | -90 | 0 | -20 | -110 |
| 2026-09-30 | 59 | 0 | -18 | 41 |
| 2026-09-29 | 100 | 0 | -10 | 90 |
| 2026-09-24 | -122 | 0 | 1 | -121 |
| 2026-09-23 | 55 | 0 | -20 | 35 |
| 2026-09-22 | 87 | 0 | -15 | 72 |
| 2026-09-21 | 34 | 0 | -23 | 11 |
| 2026-09-18 | -1 | 0 | 2 | 1 |
| 2026-09-17 | 47 | 0 | -20 | 27 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 97 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$27.30 (2026-10-19); 52-week range NT$25.05–45.80.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.